In the spring of 2024, emergency rooms across Naples were overwhelmed by something that seemed to emerge from another era—patients flooding in with the telltale yellowing of jaundice, victims of a hepatitis A outbreak that caught public health officials off guard. Within weeks, 133 cases had clustered in the Campania region alone, transforming what should have been a routine seasonal pattern into a crisis that left medical staff treating patients on stretchers in overcrowded hallways. This wasn’t supposed to happen in modern Italy, a country with sophisticated surveillance systems and decades of experience managing infectious diseases.
Yet hepatitis A has never been a respecter of modernity or borders. This ancient viral adversary has been shadowing human civilization for millennia, adapting to our changing world while exploiting the same vulnerabilities that made our ancestors susceptible thousands of years ago. From the battlefields of World War I, where it claimed millions of soldiers, to today’s interconnected European cities where a contaminated batch of shellfish can spark international outbreaks, hepatitis A continues to reveal uncomfortable truths about the persistence of infectious disease in an age of medical advancement. Italy’s recent experience offers a compelling case study of how this old foe operates in contemporary settings, challenging our assumptions about disease control and highlighting the complex interplay between cultural traditions, social inequalities, and public health preparedness.
Historical Evolution and Global Context of Hepatitis A
When we think about viral hepatitis today, it’s easy to forget that humans have been wrestling with this mysterious yellowing illness for millennia. The earliest descriptions of what we now recognize as hepatitis A stretch back an astonishing 5,000 years ago in China, making it one of humanity’s oldest documented viral adversaries. Even Hippocrates, the father of medicine himself, encountered and described a disease he termed “benign epidemic jaundice” — what we now understand to be hepatitis A. These ancient observations reveal something profound: this virus has been silently shaping human history, traveling with armies, merchants, and communities across continents long before we had any idea what a virus even was.
The military connection runs deep through hepatitis A’s historical narrative, painting a picture of how warfare inadvertently became a laboratory for understanding infectious disease. Outbreaks were regularly reported in military camps during the 17th century, and the pattern continued with devastating effect during major conflicts. The scale becomes staggering when we consider that an estimated 16 million cases were reported during World War I and World War II combined. The United States got an early taste of this reality with its first major outbreak of more than 40,000 cases in Norfolk, Virginia in 1812. These weren’t just statistics — they represented entire generations of soldiers and civilians whose lives were disrupted by a pathogen they couldn’t see or understand.
The transformation from mystery illness to understood disease represents one of medicine’s great detective stories. For centuries, all forms of viral hepatitis were lumped together under the umbrella term “epidemic jaundice,” but hepatitis A was first differentiated epidemiologically from hepatitis B during the 1940s, a breakthrough that came from careful observation of incubation periods and transmission patterns. The real eureka moment arrived in 1973 when the hepatitis A virus was finally identified, followed by the development of serologic tests in the 1970s that allowed definitive diagnosis. This scientific progression — from ancient observations to viral identification — mirrors humanity’s broader journey from superstition to understanding in medicine.
Perhaps the most remarkable chapter in this evolutionary tale is how quickly we moved from identification to prevention. Just over two decades after isolating the virus, the Food and Drug Administration approved the inactivated hepatitis A vaccine in 1995-1996, transforming hepatitis A from an inevitable part of human experience into a preventable disease. This timeline — from 5,000 years of mysterious outbreaks to vaccine development in less than 25 years — represents one of modern medicine’s most compressed success stories. Today, as we face new viral challenges, hepatitis A’s journey from ancient scourge to vaccine-preventable disease offers both hope and a roadmap for how scientific persistence can ultimately triumph over even our oldest microbial adversaries.
Building on this historical foundation, Italy has developed one of Europe’s most comprehensive surveillance systems for tracking hepatitis A’s modern manifestations.
Current Epidemiological Landscape in Italy
Italy’s surveillance system for hepatitis A offers us a fascinating window into how this ancient disease continues to evolve in modern times. Through the SEIEVA system (Sistema Epidemiologico Integrato dell’Epatite Virale Acuta), managed by Italy’s National Institute of Health, we can trace the remarkable fluctuations of hepatitis A across the peninsula over several decades. The data reveals a disease in constant motion, responding to social changes, policy interventions, and shifting demographics in ways that illuminate broader patterns of public health.
The epidemiological journey of hepatitis A in Italy tells a story of dramatic rises and falls that mirror the country’s social transformation. According to surveillance data from 1985-1994, Italy reported 25,553 acute viral hepatitis cases, with 6,408 (25%) caused by hepatitis A. What’s particularly striking is the disease’s volatility: incidence plummeted from 10 per 100,000 population in 1985 to just 2 per 100,000 in 1987, only to begin climbing again from 1991 onward. This rollercoaster pattern suggests we’re dealing with a pathogen that’s highly sensitive to environmental and behavioral factors—a characteristic that makes hepatitis A both predictable and surprisingly unpredictable.
The geographical and demographic fingerprints of hepatitis A in Italy reveal telling patterns about how the disease spreads through different communities. The surveillance data shows that cases were predominantly concentrated among 15-24 year-olds, with higher incidence rates in males and notably elevated numbers in southern Italy. Perhaps most remarkably, despite thousands of cases, only one death (0.02%) was recorded during the decade-long study period, underscoring hepatitis A’s reputation as serious but rarely fatal. Shell and seafood consumption emerged as the most frequently reported risk factor, appearing in 62% of cases—a finding that speaks to Italy’s coastal culture and culinary traditions, where raw or undercooked shellfish remain popular despite the risks.
Recent surveillance through EpiCentro’s integrated monitoring systems continues to track these evolving patterns, though the system has expanded far beyond simple case counting. Today’s surveillance integrates multiple data streams, from laboratory confirmations to epidemiological investigations, creating a more nuanced picture of how hepatitis A moves through Italian populations. The shift from basic reporting to comprehensive surveillance reflects our growing understanding that effective disease control requires not just numbers, but deep insight into the social, economic, and behavioral factors that drive transmission. This evolution in surveillance methodology has positioned Italy as a model for other countries grappling with similar challenges in tracking vaccine-preventable diseases across diverse populations.
Despite these sophisticated surveillance capabilities, recent events have demonstrated how quickly hepatitis A can overwhelm even well-prepared systems.
Recent Outbreaks and Regional Hotspots
The spring of 2024 brought an unexpected surge in hepatitis A cases to Italy, with the southern region of Campania becoming the epicenter of concern. By March 2024, Jen reported that Italy had recorded approximately 443 cases of hepatitis A throughout the year, but what alarmed health officials was the concentration of cases: 133 infections clustered in Campania over just a few weeks. This represented a dramatic departure from the typical seasonal pattern, where hepatitis A cases in the region traditionally peak in January, often linked to holiday seafood consumption habits.
Naples, Campania’s largest city, bore the brunt of this outbreak in ways that strained its healthcare infrastructure. World-today-journal documented how Cotugno Hospital admitted 43 patients with hepatitis A in March 2024 alone — a staggering increase from the usual ten mild cases typically recorded during that month. Infectious disease specialist Novella Carannante described the situation as “very acute,” with patients being treated on stretchers in emergency rooms due to overcrowding. The severity was underscored by one particularly critical case: a 46-year-old man suffering from severe liver failure who required transfer to Cardarelli Hospital for potential liver transplant evaluation.
The timing and transmission patterns of this outbreak present a complex epidemiological puzzle that highlights the insidious nature of hepatitis A. Greentechnologyinvestments noted that by March 18, 2026, the case count had reached 133 in Campania, but the virus’s lengthy incubation period — extending up to 50 days — makes tracing the exact source particularly challenging. What’s more concerning is that infected individuals can transmit the virus for up to a week before symptoms appear, creating an invisible chain of transmission that public health officials struggle to track and contain.
Public health experts have zeroed in on contaminated seafood as the primary culprit behind this regional crisis. Jen identified raw shellfish as “one of the main suspects” in the transmission, while Fabrizio Pregliasco, director of the specialization school in hygiene and preventive medicine at the University of Milan La Statale, emphasized that these outbreaks stem from “avoidable failures: insufficient controls and risky behaviors, especially regarding food.” Greentechnologyinvestments explained the biological mechanism: bivalve molluscs like mussels, clams, and oysters filter large volumes of water and can accumulate viruses from contaminated environments, making them particularly dangerous when consumed raw or undercooked.
Despite the alarming numbers, health authorities have worked to maintain perspective while strengthening response measures. Pregliasco cautioned that while 133 cases concentrated in a single region over a few weeks indicated “a local outbreak, not a national epidemic,” the situation required vigilant monitoring without panic. The response has focused on intensifying food chain controls, particularly for bivalve molluscs, and reinforcing public education about prevention. As we’ve learned from this outbreak, the intersection of cultural food traditions, seasonal consumption patterns, and inadequate safety controls can create perfect conditions for viral transmission — a reminder that even in developed countries, hepatitis A remains a formidable public health challenge requiring constant vigilance.
Understanding these outbreak patterns becomes even more critical when we consider how hepatitis A affects different age groups in dramatically different ways.
Age-Related Disease Patterns and Clinical Manifestations
The relationship between age and hepatitis A severity reveals one of the disease’s most intriguing paradoxes. While we might expect children to be more vulnerable to infectious diseases, hepatitis A operates by different rules. Research shows that approximately 70% of infections in children are asymptomatic, meaning most young patients experience the virus without even knowing they’re infected Semantic Scholar. This silent transmission among children creates a complex epidemiological puzzle, as asymptomatic carriers can unknowingly spread the virus through communities while building lifelong immunity.
Adults face a dramatically different clinical reality when encountering hepatitis A virus. Unlike their younger counterparts, adults are significantly more likely to develop symptomatic infections, often experiencing the full spectrum of hepatitis A’s clinical manifestations Semantic Scholar. The symptoms can range from mild flu-like illness to severe jaundice, fatigue, and abdominal pain that can persist for weeks or months. This age-dependent severity pattern means that adults in regions with improving sanitation—who missed childhood exposure—become increasingly vulnerable to severe disease when they eventually encounter the virus.
The clinical progression in adults can be particularly challenging, as hepatitis A causes acute liver disease that, while typically resolving without long-term consequences, can occasionally lead to acute liver failure requiring transplantation in some patients Nature. This stark contrast between pediatric and adult presentations has profound implications for public health planning. Communities transitioning from high to intermediate endemicity often see a shift where fewer children are naturally infected and protected, creating a growing population of susceptible adults who face more severe outcomes.
Understanding these age-related patterns becomes crucial for vaccination strategies and outbreak preparedness. The historical context reveals that viral hepatitis has been recognized since ancient civilizations, previously described as “epidemic jaundice,” with its contagious nature suspected even in the eighth century CE HMS Review. Today’s epidemiological data shows this ancient disease continues to challenge public health systems, particularly as demographic and socioeconomic changes alter traditional exposure patterns, making age-stratified surveillance and targeted interventions more important than ever.
These age-related vulnerabilities are further complicated by the role that food safety plays in transmission, particularly in a country with such rich culinary traditions as Italy.
Food Safety and Dietary Risk Factors
Food handlers have emerged as a critical transmission vector for hepatitis A in Italy and beyond, with recent research revealing alarming patterns that demand our attention. A comprehensive analysis of 32 studies examining HAV outbreaks linked to food workers found that index cases were “almost exclusively identified among food workers,” with most outbreaks occurring in North America and Europe. While outbreak sizes varied, the majority involved fewer than 50 confirmed patients, though researchers note the actual numbers were likely higher since many people don’t seek medical treatment or undergo specific hepatitis A testing. The timing makes this particularly concerning — symptoms may not appear until 50 days after infection and can persist for up to six weeks, creating a dangerous window where infected food handlers unknowingly contaminate food supplies.
The contamination pathway is disturbingly straightforward yet preventable. According to the FDA, “contamination of food and water can occur when an infected food handler prepares food without appropriate hand washing hygiene.” This simple breach of protocol can transform a restaurant kitchen into an epicenter of transmission. The virus’s resilience compounds the problem — hepatitis A can survive on surfaces and in food products long enough to reach consumers far from the original source. What makes this particularly insidious is that illness typically occurs within 15 to 50 days after consuming contaminated food or water, meaning the connection between a meal and subsequent symptoms often goes unrecognized.
Italy’s food surveillance efforts have revealed the scope of contamination across different food categories, though the specific findings from a six-year survey highlight the persistent challenge we face in tracking HAV through the food supply chain. The Link study’s detection of hepatitis A virus in various food categories underscores how widespread contamination can become when proper food safety protocols aren’t maintained. Contaminated seafood represents a particular risk, especially in coastal regions where raw or undercooked shellfish consumption is common. These mollusks act as biological filters, concentrating viruses from contaminated water in their tissues.
The good news is that we now have compelling evidence for an effective prevention strategy. New research published in Frontiers in Public Health demonstrates that vaccination of food handlers represents a highly effective approach to reducing hepatitis A transmission. As Food Safety News reports, “vaccination of food handlers is an effective way to reduce the spread of hepatitis A,” considering the virus’s high transmissibility. This targeted vaccination approach could be particularly valuable in Italy, where food service industries are central to both culture and economy.
For consumers, the prevention strategy remains relatively simple but requires vigilance. The FDA emphasizes that while “the majority of hepatitis A infections are from unknown causes or from being in close contact with an infected person,” food-related cases are entirely preventable through proper food handling and preparation. During outbreak periods, health authorities typically recommend avoiding raw or undercooked foods, particularly shellfish, and being extra cautious about food sourcing. The challenge lies in the fact that hepatitis A infection “may be asymptomatic” particularly in children under six, meaning infected individuals can unknowingly spread the virus through food preparation, making systematic prevention measures like food handler vaccination even more crucial.
Addressing these food safety challenges requires coordinated vaccination strategies that go beyond individual consumer protection to encompass entire food systems.
Vaccination Strategies and Prevention Measures
Italy has long been a pioneer in vaccination policy, establishing itself at the forefront of immunization strategies through its publicly funded National Health Service, which has consistently prioritized prevention campaigns and offered effective vaccines free of charge to target populations. The country’s commitment to vaccination excellence is evident in its comprehensive approach, exemplified by landmark achievements such as the extensive polio vaccination campaigns of the 1950s and 60s, and the early introduction of universal hepatitis B vaccination in 1991, as documented in Annali dell’Istituto Superiore di Sanità. This foundation of vaccination expertise has positioned Italy well to address hepatitis A prevention through systematic immunization programs.
Since the late 1990s, Italy has implemented five consecutive national vaccination plans spanning from 1999 to 2025, with the Ministry of Health’s aim evolving beyond simply extending vaccine offerings to improving delivery methods and supporting actions that ensure vaccination campaign success. The naming convention itself reflects this evolution in approach — the first two plans were called “National Vaccination Plan” (NVP), while from the third onwards, they were renamed “National Vaccination Prevention Plan” (NVPP), signaling a broader preventive health strategy, according to Annali dell’Istituto Superiore di Sanità. This systematic planning approach has been crucial for implementing hepatitis A vaccination strategies within Italy’s broader immunization framework.
The success of Italy’s vaccination programs has been notably uneven across different population groups, revealing important insights about implementation challenges. While vaccination coverage for children consistently approached target levels over the 25-year period, coverage for adolescents, the elderly, and vulnerable groups consistently fell short of established targets, as analyzed in Annali dell’Istituto Superiore di Sanità. The primary success was limited to newborn immunization, thanks to effective organizational activities, but failure to achieve goals for other population groups was partly attributed to inconsistent implementation of Regional Vaccination Prevention Plans. Regional differences also emerged, highlighting the complexity of coordinating vaccination efforts across Italy’s diverse healthcare landscape.
The effectiveness of vaccination strategies relies heavily on robust monitoring and data collection systems, which serve as the backbone for program evaluation and improvement. As emphasized by health experts, accurate recording and reporting of data represent crucial components of public health campaigns, with the monitoring of vaccination coverage and effectiveness playing an important role in determining and improving immunization programs and strategies, according to Adult Immunization Board. Italy’s participation in international surveillance networks, including projects addressing hepatitis A and B surveillance and prevention across EU countries, demonstrates its commitment to evidence-based vaccination policy, as noted in Eurohep.
The WHO’s comprehensive outbreak toolkit for hepatitis A provides additional context for Italy’s prevention strategies, offering standardized approaches for surveillance, response, and vaccination protocols that complement national programs, as outlined in WHO. This international framework supports Italy’s domestic vaccination efforts by providing evidence-based guidelines for hepatitis A prevention, particularly important given the disease’s potential for outbreak scenarios and the need for coordinated public health responses that extend beyond routine immunization schedules.
These national vaccination efforts are increasingly being coordinated within a broader European framework that recognizes hepatitis A as a cross-border challenge requiring continental cooperation.
Public Health Response and Future Outlook
The European surveillance landscape for hepatitis A has evolved into a sophisticated network that tracks outbreaks across borders with remarkable precision. When we examine recent multi-country outbreaks, like the significant surge documented between January and May 2025 affecting Austria, Czechia, Hungary, and Slovakia, we see how modern genetic sequencing can identify closely related viral clusters spanning multiple nations. ECDC coordinates this continental surveillance through their comprehensive reporting system, producing annual epidemiological reports that have become essential tools for understanding transmission patterns. The numbers tell a striking story: Austria reported 87 confirmed cases with 68% being male and a median age of 34, already surpassing their entire 2024 total, while Czechia documented 600 confirmed cases and Hungary reported 530 cases during this outbreak period. Id-ea
What makes current outbreak management particularly effective is the ability to identify vulnerable populations with laser-like accuracy. The 2025 European outbreak primarily affected adults experiencing homelessness, people who use or inject drugs, those living in poor sanitary conditions, and members of Roma communities. Id-ea Children in Roma populations were notably affected, especially in Slovakia and Czechia, highlighting how hepatitis A continues to exploit social inequalities and inadequate sanitation infrastructure. This pattern isn’t new—we’ve seen similar demographic clustering in previous outbreaks—but our ability to respond rapidly has improved dramatically through coordinated surveillance networks that can track subgenotype IB variants across borders in real-time.
The integration of Italy into this broader European surveillance framework represents a significant advancement in public health capacity. Healthinformationportal demonstrates how national health systems now contribute to a unified continental approach to infectious disease monitoring. This collaborative model allows for rapid identification of transmission patterns that might otherwise go undetected at the national level. The hospitalization rates and mortality data—including three deaths documented in the Austrian portion of the 2025 outbreak—underscore the continued serious nature of hepatitis A despite our enhanced surveillance capabilities. Id-ea
Looking toward future hepatitis A control in Italy and across Europe, the evidence suggests we need more targeted interventions for high-risk populations rather than broad-based approaches. The systematic literature reviews covering the last two decades of European hepatitis A epidemiology reveal evolving patterns that demand adaptive public health strategies. Pubmed The concentration of cases among marginalized communities—particularly those experiencing homelessness and living in poor sanitary conditions—indicates that traditional vaccination campaigns may miss the most vulnerable populations. Enhanced outbreak management protocols should focus on rapid deployment of resources to these communities, coupled with improved sanitation infrastructure and targeted vaccination efforts that meet people where they are, rather than waiting for them to access traditional healthcare systems.
Conclusion
The story of hepatitis A in Italy reveals a complex interplay between ancient viral persistence and modern public health innovation. From the overwhelmed emergency rooms of Naples in 2024 to the sophisticated European surveillance networks that can track viral variants across continents, we see how a pathogen that has shadowed humanity for millennia continues to test our preparedness in unexpected ways. Italy’s experience demonstrates both the power and limitations of our current approach: comprehensive surveillance systems that can map transmission patterns with remarkable precision, yet outbreaks that still catch communities off guard and exploit persistent inequalities in healthcare access and sanitation infrastructure.
The evidence points toward a future where hepatitis A control will require increasingly targeted and nuanced interventions. Traditional broad-based vaccination campaigns, while valuable, may prove insufficient in addressing the disease’s concentration among marginalized populations—the homeless, drug users, and communities with poor sanitation access who often remain invisible to conventional healthcare systems. Italy’s integration into European surveillance networks offers hope for rapid response capabilities, but the 2024 Campania outbreak and the broader 2025 European surge remind us that even sophisticated monitoring systems cannot prevent outbreaks that exploit fundamental social vulnerabilities. As we look ahead, perhaps the most pressing question is not whether we have the technological tools to control hepatitis A, but whether we have the political will to address the underlying inequalities that allow this ancient virus to persist in modern Europe?
